Trial: 202007111

A Phase 1, Open-label Study to Evaluate the Safety, Pharmacokinetics, and Anti-Tumor Activity of Oral EPI-7386 in Patients with Metastatic Castration-Resistant Prostate Cancer

Phase

I

Principal Investigator

Pachynski, Russell

Disease Site

Metastatic Disease; Prostate

Learn more about this study at: clinicaltrials.gov